Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:22 pm Purchase | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 3,861,347 6.310% | 1,185,247 (+44.29%) | Filing History |
| 2022-02-14 4:13 pm Purchase | 2021-01-19 | 13G | Aclaris Therapeutics, Inc. ACRS | Venrock Healthcare Capital Partners II, L.P. | 4,563,962 7.500% | 4,563,962 (New Position) | Filing History |
| 2022-02-11 3:12 pm Sale | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Foresite Capital Fund III L.P. | 4,657,277 7.600% | -1,954,904 (-29.57%) | Filing History |
| 2022-02-10 2:17 pm Sale | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Renaissance Technologies LLC | 1,676,878 2.740% | -1,591,300 (-48.69%) | Filing History |
| 2022-02-10 08:54 am Sale | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 899,997 1.470% | -1,350,003 (-60.00%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | BlackRock Inc. BLK | 4,078,875 6.700% | 3,031,059 (+289.27%) | Filing History |
| 2022-02-04 09:12 am Purchase | 2021-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Wellington Management Group LLP | 5,539,268 9.050% | 5,539,268 (New Position) | Filing History |
| 2022-01-24 5:23 pm Purchase | 2022-01-13 | 13G | Aclaris Therapeutics, Inc. ACRS | BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.300% | 3,868,043 (New Position) | Filing History |
| 2021-02-16 4:32 pm Purchase | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 2,676,100 6.240% | 462,244 (+20.88%) | Filing History |
| 2021-02-12 3:18 pm Sale | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | EcoR1 Capital, LLC | 1,509,812 3.500% | -577,500 (-27.67%) | Filing History |
| 2021-02-11 2:56 pm Purchase | 2021-02-05 | 13G | Aclaris Therapeutics, Inc. ACRS | Foresite Capital Fund III L.P. | 6,612,181 13.700% | 4,381,241 (+196.39%) | Filing History |
| 2021-02-11 07:29 am Sale | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,250,000 5.240% | -250,000 (-10.00%) | Filing History |
| 2021-02-10 8:48 pm Purchase | 2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | Renaissance Technologies LLC | 3,268,178 7.610% | 485,881 (+17.46%) | Filing History |
| 2020-10-26 7:47 pm Purchase | 2020-10-20 | 13G | Aclaris Therapeutics, Inc. ACRS | Foresite Capital Fund III L.P. | 2,230,940 5.200% | 2,230,940 (New Position) | Filing History |
| 2020-10-26 4:49 pm Purchase | 2020-10-14 | 13G | Aclaris Therapeutics, Inc. ACRS | Rock Springs Capital Management LP | 2,213,856 5.180% | 613,856 (+38.37%) | Filing History |